Back to Authors

Wruck, Lisa M

0000-0003-1732-9067

Mayo Clinic

Duke Clinical Research Institute, Durham, NC, USA.

Citations 14

Mild cognitive impairment and dementia prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study
Sharrett, Albert Richey, Wruck, Lisa , Windham, B. Gwen , Coker, Laura H., Schneider, Andrea L.C. , Sun, Hengrui, Alonso, Álvaro , Albert, Marilyn S. , Knopman, David S. , Gottesman, Rebecca F. , Sharrett, A. Richey, Coresh, Josef , Mosley, Thomas H. , Alonso, Alvaro , Schneider, Andrea L C , Wruck, Lisa M

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | January 4, 2016 | Volume: 2 | Issue: 1 | Pages: 1-11

10.1016/j.dadm.2015.12.002 Get It

AbstractIntroductionWe examined prevalence of mild cognitive impairment (MCI) and dementia in the Atherosclerosis Risk in Communities (ARIC) Neurocognitive study.MethodsBeginning in June, 2011, we invited all surviving ARIC participants to undergo cognitive, neurologic, and brain imaging assessments to diagnose MCI or dementia and assign an etiology for the cognitive disorder.ResultsOf 10,713 surviving ARIC participants (age range, 69–88 years), we ascertained cognitive diagnoses in 6471 in person, 1966 by telephone interviews (participant or informant), and the remainder by medical record review. The prevalence of dementia was 9.0% and MCI 21%. Alzheimer's disease (AD) was the primary or secondary etiology in 76% of dementia and 75% of MCI participants. Cerebrovascular disease was the primary or secondary etiology in 46% of dementia and 32% of MCI participants.DiscussionMCI and dementia were common among survivors from the original ARIC cohort. Nearly 30% of the ARIC cohort received diagnoses of either dementia or MCI, and for the majority of these individuals, the etiologic basis was attributed to AD.
Vascular Imaging Abnormalities and Cognition
Griswold, Michael , Lirette, Seth T. , Kantarci, Kejal , Sharrett, A. Richey , Graff‐Radford, Jonathan , Schneider, Andrea L.C. , Windham, B. Gwen , Coker, Laura H., Albert, Marilyn , Wruck, Lisa , Knopman, David S. , Gottesman, Rebecca F. , Jack, Clifford R. , Mosley, Thomas H. , Kantarci, Kejal , Lirette, Seth , Schneider, Andrea L C , Wruck, Lisa M

Stroke | January 7, 2015 | Volume: 46 | Issue: 2 | Pages: 433-440

10.1161/strokeaha.114.007847 Get It

Background and Purpose— The relationships between cerebrovascular lesions visible on imaging and cognition are complex. We explored the possibility that the cerebral cortical volume mediated these relationships. Methods— Total of 1906 nondemented participants (59% women; 25% African–American; mean age, 76.6 years) in the Atherosclerosis Risk in Communities (ARIC) study underwent cognitive assessments, risk factor assessments, and quantitative MRI for white matter hyperintensities (WMH) and infarcts. The Freesurfer imaging analysis pipeline was used to determine regional cerebral volumes. We examined the associations of cognitive domain outcomes with cerebral volumes (hippocampus and separate groups of posterior and frontal cortical regions of interest) and cerebrovascular imaging features (presence of large or small cortical/subcortical infarcts and WMH volume). We performed mediation pathway analyses to assess the hypothesis that hippocampal and cortical volumes mediated the associations between cerebrovascular imaging features and cognition. Results— In unmediated analyses, WMH and infarcts were both associated with worse psychomotor speed/executive function. In mediation analyses, WMH and infarct associations on psychomotor speed/executive function were significantly attenuated, but not abolished, by the inclusion of the posterior cortical regions of interest volume in the models, and the infarcts on psychomotor speed/executive function association were attenuated, but not abolished, by inclusion of the frontal cortical regions of interest volume. Conclusions— Both WMH and infarcts were associated with cortical volume, and both lesions were also associated with cognitive performance, implying shared pathophysiological mechanisms. Although cross-sectional, our findings suggest that WMH and infarcts could be proxies for clinically covert processes that directly damage cortical regions. Microinfarcts are 1 candidate for such a clinically covert process.
Impact of Atrial Fibrillation on Healthcare Utilization in the Community: The Atherosclerosis Risk in Communities Study
Bengtson, Lindsay G.S. , Lutsey, Pamela L. , Loehr, Laura R. , Kucharska‐Newton, Anna , Chen, Lin Y. , Chamberlain, Alanna M. , Wruck, Lisa , Duval, Sue , Alonso, Álvaro , Stearns, Sally C. , Alonso, Alvaro , Chamberlain, Alanna M , Chen, Lin Y , Lutsey, Pamela L , Kucharska-Newton, Anna M , Wruck, Lisa M

Journal of the American Heart Association | October 31, 2014 | Volume: 3 | Issue: 6 | Pages: No page available

10.1161/jaha.114.001006 Get It

Background Atrial fibrillation ( AF ) is associated with increased risk of hospitalization. Little is known about the impact of AF on utilization of noninpatient health care or about sex or race differences in AF ‐related utilization. We examined rates of inpatient and outpatient utilization by AF status in the Atherosclerosis Risk in Communities study. Methods and Results Participants with incident AF enrolled in fee‐for‐service Medicare for at least 12 continuous months between 1991 and 2009 (n=932) were matched on age, sex, race and field center with up to 3 participants without AF (n=2729). Healthcare utilization was ascertained from Medicare claims and classified by primary International Classification of Diseases, ninth revision code. The average annual numbers of days hospitalized were 13.2 (95% CI 11.6 to 15.0) and 2.8 (95% CI 2.5 to 3.1) for those with and without AF , respectively. The corresponding numbers of annual outpatient claims were 53.3 (95% CI 50.5 to 56.3) and 22.9 (95% CI 22.1 to 23.8) for those with and without AF , respectively. Most utilization among AF patients was attributable to non‐ AF conditions. The adjusted rate ratio for annual days hospitalized for other cardiovascular disease–related reasons was 4.58 (95% CI : 3.41 to 6.16) for those with AF versus those without AF . The association between AF and healthcare utilization was similar among men and women and among white and black participants. Conclusions Participants with AF had considerably greater healthcare utilization, and the difference in utilization for other cardiovascular disease –related reasons was substantial. In addition to rate or rhythm treatment, AF management should focus on the accompanying cardiovascular comorbidities.